Aprea Therapeutics Inc
APRE
$0.62+5.93%
End of day · as of Oct 16, 2026, 8:01 AM ET
Mkt cap
$10.40M
EV/Sales
N/A
P/E ratio
N/A
Revenue (FY2025)
N/A
EPS (H1 2026)
$-0.20
Gross Margin (FY2025)
N/A
Profit Margin (FY2025)
N/A
Beta
1.61
Div yield
N/A
Sector
Healthcare
Aprea Therapeutics Inc (APRE) is a biotechnology company listed on US.
Use this APRE research hub for sector, financials, and filings — not a live tape.
Latest cached year on this hub. Full APRE income, balance, and cash tables.
Aprea Therapeutics Inc (APRE) is a biotechnology company in the Healthcare sector.
Latest cached Aprea Therapeutics Inc (APRE) net income for FY2025 was -$12.6M. Statements: https://lician.com/financials/apre
Aprea Therapeutics Inc (APRE) market capitalization is $10.4M on the latest cached snapshot.
Aprea Therapeutics Inc (APRE) cached previous close $0.58; day range $0.58 – $0.63; volume 64,442. Session quote: https://lician.com/quote/apre
Aprea Therapeutics Inc (APRE) latest cached earnings event is "APRE earnings" on Aug 12, 2026. Earnings calendar: https://lician.com/earnings
The latest cached APRE filing is 8-K · Aug 28, 2026. Filings: https://lician.com/sec/apre